AK
Ankit Kumar Lalit Kumar Jain
About Ankit Kumar Lalit Kumar Jain
Data last updated:
Ankit Kumar Lalit Kumar Jain has 6 years in corporate governance. Holds Additional Director role. Currently with 1 company, including Honeybell Pharma Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Honeybell Pharma Private Limited at ₹18.91 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Honeybell Pharma Private Limited U74999MH2018PTC316948 | Additional Director | 29 Sep 2020 | 2018 | ₹18.91 Cr (FY 2024) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ankit Kumar Lalit Kumar Jain
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ankit Kumar Lalit Kumar Jain
Ankit Kumar Lalit Kumar Jain has 6 years in corporate governance. Holds Additional Director role. Currently with 1 company, including Honeybell Pharma Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Honeybell Pharma Private Limited at ₹18.91 Cr (FY 2024).
Ankit Kumar Lalit Kumar Jain is associated with 1 company as Additional Director, including Honeybell Pharma Private Limited (₹18.91 Cr).
Ankit Kumar Lalit Kumar Jain has expertise in General Business.
Ankit Kumar Lalit Kumar Jain has 6 years in corporate governance.
By reported revenue, the largest current company of Ankit Kumar Lalit Kumar Jain is Honeybell Pharma Private Limited, with revenue of ₹18.91 Cr (FY 2024).
Ankit Kumar Lalit Kumar Jain currently holds positions at 1 company: Honeybell Pharma Private Limited (₹18.91 Cr).